Skip to main content
. 2022 Nov 9;12(11):1087. doi: 10.3390/metabo12111087

Figure 4.

Figure 4

Mean plot of SM 42:2, SM42:3 among LC, LBT, and HC groups (SM 42:2: sphingomyelin 42:2; SM 42:3, sphingomyelin 42:3; LC, laryngeal cancer patients; LBT, laryngeal benign tumor patients; HC, healthy crowds).